Susan B Duel

US Patent:

57467153, May 5, 1998

Filed:

Jun 28, 1996

Appl. No.:

8/673446

Inventors:

Terrence Bruce Mazer - Reynoldsburg OH
Joseph Edward Walton - Westerville OH
Ronita Kay Geckle - Columbus OH
Carl Joseph Piontek - Powell OH
Susan Beth Duel - Laurinburg NC
Andre Daab-Krzykowski - Columbus OH
Robert Louis Joseph - Columbus OH
William Guy Pierson - Canal Winchester OH
Thomas Daniel Loughrin - Columbus OH
Thomas Walter Osip - Dublin OH

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61M 3700

US Classification:

604 83

Abstract:

A method for dye marking a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient includes the steps of: (1) providing apparatus such as a formulation chamber, e. g. , a drip chamber, connectable to the supply container, with at least one sustained release reservoir containing a physiologically acceptable and dispersible marker dye positioned within the formulation chamber, and, liquid communication means connecting the formulation chamber to the feeding tube of a patient; (2) providing a supply container containing the nutritional product; (3) connecting the formulation chamber to the supply container and the liquid commmunication means to the feeding tube; and (4) flowing the dye-marked nutritional product through the apparatus and into the feeding tube. The sustained release reservoir may be a conventional slow release coated tablet, microspheres, or capsule type or an osmotically driven device. The marker dye may be a colorant dye or a fluorescing dye or a mixture thereof.

US Patent:

55316816, Jul 2, 1996

Filed:

Jan 13, 1995

Appl. No.:

8/372407

Inventors:

Joseph E. Walton - Westerville OH
Terrence B. Mazer - Reynoldsburg OH
Ronita K. Geckle - Columbus OH
Carl J. Piontek - Powell OH
Susan B. Duel - Laurinburg NC
Andre Daab-Krzykowski - Columbus OH
Mark A. McCamish - Worthington OH
Robert L. Joseph - Columbus OH
William G. Pierson - Canal Winchester OH

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61M 3700

US Classification:

604 83

Abstract:

An apparatus is disclosed for modifying a liquid enteral nutritional product during delivery thereof from a supply thereof, such as a hangable container, to a feeding tube delivering the liquid enteral nutritional product to the gastrointestinal tract of a patient. The apparatus has at least one formulation chamber, such as a drip chamber, with at least one controlled release dosage form unit in the form of a coated tablet, osmotically driven device, coated capsule, microencapsulated microspheres, agglomerated molecular sieving type material, or a quantity of fine hollow permeable fibers located therein. The controlled release dosage form unit or units contain at least one beneficial agent selected from nutrients, medicaments, probiotics, or diagnostic agents or mixtures thereof, to any of which a physiologically acceptable marker dye in controlled release dosage form and/or the same or different beneficial agent not in controlled release dosage form may be added. A liquid nutritional product flows through the formulation chamber during enteral tube feeding of a patient.

US Patent:

55317340, Jul 2, 1996

Filed:

Jan 13, 1995

Appl. No.:

8/372408

Inventors:

Ronita K. Geckle - Columbus OH
Terrence B. Mazer - Reynoldsburg OH
Joseph E. Walton - Westerville OH
Carl J. Piontek - Powell OH
Susan B. Duel - Laurinburg NC
Andre Daab-Krzykowski - Columbus OH
Mark A. McCamish - Worthington OH
Robert L. Joseph - Columbus OH
William G. Pierson - Canal Winchester OH

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61K 922

US Classification:

6048901

Abstract:

A method is disclosed for modifying a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient. During enteral tube feeding the nutritional product passes through a formulation chamber, e. g. , a drip chamber, having located therein at least one controlled release dosage form unit containing at least one beneficial agent. The beneficial agent may be selected from nutrients, medicaments, probiotics, or diagnostic agents or mixtures thereof, and any such together with a physiologically acceptable marker dye in controlled release dosage form and/or the same or different additional beneficial agent not in controlled release dosage form. Controlled release dosage forms may be of a conventional sustained release type or an osmotically driven delivery device.

US Patent:

57412430, Apr 21, 1998

Filed:

Jul 1, 1996

Appl. No.:

8/673941

Inventors:

Ronita Kay Geckle - Columbus OH
Terrence Bruce Mazer - Reynoldsburg OH
Joseph Edward Walton - Westerville OH
Carl Joseph Piontek - Powell OH
Susan Beth Duel - Laurinburg NC
Andre Daab-Krzykowski - Columbus OH
Mark Anthony McCamish - Worthington OH
Robert Louis Joseph - Columbus OH
William Guy Pierson - Canal Winchester OH

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61K 922

US Classification:

6048901

Abstract:

A method is disclosed for modifying a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient. During enteral tube feeding the nutritional product passes through a formulation chamber, e. g. , a drip chamber, having located therein at least one controlled release dosage form unit containing at least one beneficial agent. The beneficial agent may be selected from nutrients, medicaments, probiotics, or diagnostic agents or mixtures thereof, and any such together with a physiologically acceptable marker dye in controlled release dosage form and/or the same or different additional beneficial agent not in controlled release dosage form. Controlled release dosage forms may be of a conventional sustained release type or an osmotically driven delivery device.

US Patent:

57386510, Apr 14, 1998

Filed:

Jun 28, 1996

Appl. No.:

8/673449

Inventors:

Joseph Edward Walton - Westerville OH
Terrence Bruce Mazer - Reynoldsburg OH
Ronita Kay Geckle - Columbus OH
Carl Joseph Piontek - Powell OH
Susan Beth Duel - Laurinburg NC
Andre Daab-Krzykowski - Columbus OH
Mark Anthony McCamish - Worthington OH
Robert Louis Joseph - Columbus OH
William Guy Pierson - Canal Winchester OH

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61M 3700

US Classification:

604 83

Abstract:

An apparatus is disclosed for modifying a liquid enteral nutritional product during delivery thereof from a supply thereof, such as a hangable container, to a feeding tube delivering the liquid enteral nutritional product to the gastrointestinal tract of a patient. The apparatus has at least one formulation chamber, such as a drip chamber, with at least one controlled release dosage form unit in the form of a coated tablet, osmotically driven device, coated capsule, microencapsulated microspheres, agglomerated molecular sieving type material, or a quantity of fine hollow permeable fibers located therein. The controlled release dosage form unit or units contain at least one beneficial agent selected from nutrients, medicaments, probiotics, or diagnostic agents or mixtures thereof, to any of which a physiologically acceptable marker dye in controlled release dosage form and/or the same or different beneficial agent not in controlled release dosage form may be added. A liquid nutritional product flows through the formulation chamber during enteral tube feeding of a patient.

US Patent:

57556890, May 26, 1998

Filed:

Jun 28, 1996

Appl. No.:

8/671876

Inventors:

Terrence Bruce Mazer - Reynoldsburg OH
Joseph Edward Walton - Westerville OH
Ronita Kay Geckle - Columbus OH
Carl Joseph Piontek - Powell OH
Susan Beth Duel - Laurinburg NC
Andre Daab-Krzykowski - Columbus OH
Robert Louis Joseph - Columbus OH
William Guy Pierson - Canal Winchester OH
Thomas Daniel Loughrin - Columbus OH
Thomas Walter Osip - Dublin OH

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61M 3700

US Classification:

604 84

Abstract:

An apparatus is useful for dye marking a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient. A formulation chamber, such as a drip chamber, is connectable to the supply container. At least one sustained release reservoir containing a physiologically acceptable marker dye is positioned within the formulation chamber, or if not, is included as part of a kit. The sustained release reservoir may be in the form of a coated tablet, osmotically driven device, coated capsule, microencapsulated microspheres, agglomerated molecular sieving material, or chopped hollow fibers having permeable walls. A liquid communication means connects the formulation chamber to the feeding tube of a patient. The marker dye may be a colorant dye or a fluorescing dye or a mixture thereof.

US Patent:

55495508, Aug 27, 1996

Filed:

Jan 13, 1995

Appl. No.:

8/372613

Inventors:

Terrence B. Mazer - Reynoldsburg OH
Joseph E. Walton - Westerville OH
Ronita K. Geckle - Columbus OH
Carl J. Piontek - Powell OH
Susan B. Duel - Laurinburg NC
Andre Daab-Krzykowski - Columbus OH
Robert L. Joseph - Columbus OH
William G. Pierson - Canal Winchester OH
Thomas D. Loughrin - Columbus OH
Thomas W. Osip - Dublin OH

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61M 3700

US Classification:

604 83

Abstract:

A method for dye marking a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient includes the steps of: (1) providing apparatus such as a formulation chamber, e. g. , a drip chamber, connectable to the supply container, with at least one sustained release reservoir containing a physiologically acceptable and dispersible marker dye positioned within the formulation chamber, and, liquid communication means connecting the formulation chamber to the feeding tube of a patient; (2) providing a supply container containing the nutritional product; (3) connecting the formulation chamber to the supply container and the liquid commmunication means to the feeding tube; and (4) flowing the dye-marked nutritional product through the apparatus and into the feeding tube. The sustained release reservoir may be a conventional slow release coated tablet, microspheres, or capsule type or an osmotically driven device. The marker dye may be a colorant dye or a fluorescing dye or a mixture thereof.

US Patent:

55316824, Jul 2, 1996

Filed:

Jan 13, 1995

Appl. No.:

8/372266

Inventors:

Terrence B. Mazer - Reynoldsburg OH
Joseph E. Walton - Westerville OH
Ronita K. Geckle - Columbus OH
Carl J. Piontek - Powell OH
Susan B. Duel - Laurinburg NC
Andre Daab-Krzykowski - Columbus OH
Robert L. Joseph - Columbus OH
William G. Pierson - Canal Winchester OH
Thomas D. Loughrin - Columbus OH
Thomas W. Osip - Dublin OH

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61M 3700

US Classification:

604 84

Abstract:

An apparatus is useful for dye marking a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient. A formulation chamber, such as a drip chamber, is connectable to the supply container. At least one sustained release reservoir containing a physiologically acceptable marker dye is positioned within the formulation chamber, or if not, is included as part of a kit. The sustained release reservoir may be in the form of a coated tablet, osmotically driven device, coated capsule, microencapsulated microspheres, agglomerated molecular sieving material, or chopped hollow fibers having permeable walls. A liquid communication means connects the formulation chamber to the feeding tube of a patient. The marker dye may be a colorant dye or a fluorescing dye or a mixture thereof.